NO20005352L - Paroksetinaskorbat - Google Patents

Paroksetinaskorbat

Info

Publication number
NO20005352L
NO20005352L NO20005352A NO20005352A NO20005352L NO 20005352 L NO20005352 L NO 20005352L NO 20005352 A NO20005352 A NO 20005352A NO 20005352 A NO20005352 A NO 20005352A NO 20005352 L NO20005352 L NO 20005352L
Authority
NO
Norway
Prior art keywords
ascorbate
useful
treatment
cns disorders
certain cns
Prior art date
Application number
NO20005352A
Other languages
English (en)
Other versions
NO20005352D0 (no
Inventor
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005352D0 publication Critical patent/NO20005352D0/no
Publication of NO20005352L publication Critical patent/NO20005352L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Paroksetinaskorbat er nyttig ved behandling av visse CNS-lidelser.
NO20005352A 1998-04-25 2000-10-24 Paroksetinaskorbat NO20005352L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound
PCT/GB1999/001244 WO1999055698A1 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate

Publications (2)

Publication Number Publication Date
NO20005352D0 NO20005352D0 (no) 2000-10-24
NO20005352L true NO20005352L (no) 2000-10-24

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005352A NO20005352L (no) 1998-04-25 2000-10-24 Paroksetinaskorbat

Country Status (20)

Country Link
EP (1) EP1089995A1 (no)
JP (1) JP2002513019A (no)
KR (1) KR20010042977A (no)
CN (1) CN1297448A (no)
AP (1) AP2000001963A0 (no)
AU (1) AU3618499A (no)
BG (1) BG104940A (no)
BR (1) BR9909868A (no)
CA (1) CA2330055A1 (no)
EA (1) EA200001104A1 (no)
GB (1) GB9808896D0 (no)
HU (1) HUP0102116A3 (no)
ID (2) ID26083A (no)
IL (1) IL139081A0 (no)
NO (1) NO20005352L (no)
PL (1) PL343677A1 (no)
SK (1) SK15912000A3 (no)
TR (1) TR200003084T2 (no)
WO (1) WO1999055698A1 (no)
ZA (1) ZA200005912B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
WO2003057650A2 (en) 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
CN110607553B (zh) * 2018-10-30 2024-03-22 中国科学院化学研究所 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (es) * 1996-02-29 1999-07-01 Ferrer Int Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.

Also Published As

Publication number Publication date
TR200003084T2 (tr) 2001-02-21
SK15912000A3 (sk) 2001-04-09
ID26083A (id) 2000-11-23
EA200001104A1 (ru) 2001-04-23
ZA200005912B (en) 2001-12-19
CN1297448A (zh) 2001-05-30
AP2000001963A0 (en) 2000-12-31
NO20005352D0 (no) 2000-10-24
IL139081A0 (en) 2001-11-25
KR20010042977A (ko) 2001-05-25
PL343677A1 (en) 2001-08-27
ID26654A (id) 2001-01-25
GB9808896D0 (en) 1998-06-24
EP1089995A1 (en) 2001-04-11
HUP0102116A2 (hu) 2002-05-29
WO1999055698A1 (en) 1999-11-04
AU3618499A (en) 1999-11-16
BG104940A (bg) 2001-09-28
BR9909868A (pt) 2000-12-19
CA2330055A1 (en) 1999-11-04
HUP0102116A3 (en) 2002-12-28
JP2002513019A (ja) 2002-05-08

Similar Documents

Publication Publication Date Title
NO20032254L (no) Forbindelser for inhibering av ekspresjon av VACM-I
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
NO975747D0 (no) Peptidylheterocykler for anvendelse ved behandling av trombin-relaterte mangler
NZ335981A (en) Ketobenzamides as calpain inhibitors
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20003211D0 (no) Triazinforbindelser for behandling av CNS forstyrrelser
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
BR0012921A (pt) Compostos calcilìticos
BG100248A (bg) Инхибитори на скваленсинтетаза
NO990450D0 (no) Behandling av sinnslidelser
AP2000001963A0 (en) Paroxetine ascorbate.
NO20011892L (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
DK1133296T3 (da) Ny terapeutisk anvendelse af nicergolin
NO20010390D0 (no) Behandling av angstsykdommer
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
DE69917445D1 (de) Reinigung von carboxaldehyd
NO992021D0 (no) FramgangsmÕte for pulpbehandling av tremasse
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
YU22802A (sh) Izonipekotamidi za lečenje poremećaja nastalih posredstvom integrina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application